IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Wednesday reported fourth-quarter earnings of $335.3 million.

The Irvine, California-based company said it had profit of 53 cents per share. Earnings, adjusted for non-recurring gains, were 51 cents per share.

The results did not meet Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of 55 cents per share.

The medical device maker posted revenue of $1.33 billion in the period, also missing Street forecasts. Nine analysts surveyed by Zacks expected $1.34 billion.

For the year, the company reported profit of $1.5 billion, or $2.38 per share. Revenue was reported as $5.23 billion.

For the current quarter ending in April, Edwards Lifesciences expects its per-share earnings to range from 54 cents to 62 cents.

The company said it expects revenue in the range of $1.27 billion to $1.35 billion for the fiscal first quarter.

Edwards Lifesciences expects full-year earnings in the range of $2.50 to $2.65 per share, with revenue ranging from $5.5 billion to $6 billion.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EW at https://www.zacks.com/ap/EW

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News